http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011520988-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-46
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-24
filingDate 2009-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2011520988-A
titleOfInvention Salts and polymorphs of tetracycline compounds
abstract Crystal forms including salts and polymorphs of compounds useful in the treatment of tetracycline compound responsive states are provided herein. The crystalline compounds are generally useful not only for the treatment or prevention of conditions and disorders such as bacterial infections and neoplasms, but also for other known uses for tetracycline compounds.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019520363-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7225088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019203007-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019524767-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018506539-A
priorityDate 2008-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004502752-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005526754-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004502753-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467208807

Total number of triples: 41.